In vitro activity of three carbapenem antibiotics comparative studies with biapenem (L-627), imipenem, and meropenem against aerobic pathogens isolated worldwide
- 31 December 1993
- journal article
- research article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 17 (4), 299-305
- https://doi.org/10.1016/0732-8893(93)90039-a
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- In vitro activity of L-627, a new carbapenemAntimicrobial Agents and Chemotherapy, 1992
- In vitro activity and beta-lactamase stability of LJC 10,627Antimicrobial Agents and Chemotherapy, 1992
- Renal dehydropeptidase-I stability of LJC 10,627, a new carbapenem antibioticAntimicrobial Agents and Chemotherapy, 1992
- In-vitro activity of new carbapenem antibiotics: comparative studies with meropenem, L-627 and imipenem against pathogenic Nocardia spp.Journal of Antimicrobial Chemotherapy, 1992
- In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase IAntimicrobial Agents and Chemotherapy, 1991
- The carbapenems and penem antibiotics—a brief reviewAntimicrobic Newsletter, 1990
- In vitro antibacterial activity and beta-lactamase stability of the new carbapenem LJC10,627European Journal of Clinical Microbiology & Infectious Diseases, 1990
- In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase IAntimicrobial Agents and Chemotherapy, 1990